Mucins Differently Expressed in Various Ampullary Adenocarcinomas

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2011 Oct 27

PMID 22027009

Citations 8

Authors

Tao Wang

Ye M Liang

Peng Hu

Yu F Cheng

Affiliations

Soon will be listed here.

Abstract

Background: We investigated the occurrence and clinical significance of mucin expression in ampullary adenocarcinoma.

Methods: We retrospectively analyzed clinical, pathological, and survival data from 74 ampullary adenocarcinoma patients who received radical operation from January 2004 to November 2006.

Results: The tumors were located in the lower end of the common bile duct (46%), papillary duodenum (42%), and ampullary duodenum (12%), and expressed MUC1 (72%), MUC2 (20%), MUC5AC (43%), and MUC6 (27%). Expression of MUC1 was associated with tumor differentiation (OR: 4.71, 95% CI: 1.26, 17.66, P = 0.021). Expression of MUC5AC was associated with age (OR: 1.07, 95% CI: 1.11, 1.14, P = 0.026) and less vessel invasion(OR: 0.14, 95% CI: 0.03, 0.72, P = 0.019). The survival rates were not significantly different when patients had or had no expression of MUC1, MUC2, MUC5AC, or MUC6 in tumor. Patients with tumors positive for MUC5AC in the papillary duodenum had worse survival than those with tumors negative for MUC5AC (P = 0.044).

Conclusions: Expression of MUC1 was high (72%) in ampullary adenocarcinoma, while expressions of MUC2, MUC5AC, and MUC6 were lower. Mucins are useful markers to diagnose and identify ampullary adenocarcinoma, particularly in determining the degree of malignancy of ampullary adenocarcinoma.

Citing Articles

Prognostic Impact of Mucin Expression in Curatively Resected Ampulla of Vater Cancer.

Noh B, Seo H, Park Y, Song S, Kim S, Hong S Cancers (Basel). 2024; 16(11).

PMID: 38893239 PMC: 11171239. DOI: 10.3390/cancers16112120.

Molecular Aberrations in Periampullary Carcinoma.

Tewari M, Swain J, Dixit V, Shukla H Indian J Surg Oncol. 2022; 8(3):348-356.

PMID: 36118392 PMC: 9478047. DOI: 10.1007/s13193-017-0645-2.

Rare histological subtype of invasive micropapillary carcinoma in the ampulla of Vater: A case report.

Noguchi H, Higashi M, Idichi T, Kurahara H, Mataki Y, Tasaki T World J Clin Cases. 2021; 9(11):2671-2678.

PMID: 33889635 PMC: 8040169. DOI: 10.12998/wjcc.v9.i11.2671.

Laterally Spreading Adenocarcinoma Involving the Lower Bile Duct and Duodenum Expressing Heterogeneous Immunohistochemical Phenotypes.

Miyabe K, Notohara K, Asano G, Kachi K, Kato A, Natsume M Intern Med. 2019; 58(21):3087-3092.

PMID: 31292382 PMC: 6875461. DOI: 10.2169/internalmedicine.2801-19.

Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

da Silveira Santos J, Machado C, Paulino Junior E, Rodrigues J, Vidigal P, Resende V J Gastrointest Surg. 2018; 22(7):1171-1178.

PMID: 29736668 DOI: 10.1007/s11605-018-3797-7.

References

Yonezawa S, Horinouchi M, Osako M, Kubo M, Takao S, Arimura Y . Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol Int. 1999; 49(1):45-54. DOI: 10.1046/j.1440-1827.1999.00823.x. View

Lee M, Lee H, Kim W, Choi Y, Yang M . Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003; 16(5):403-10. DOI: 10.1097/01.MP.0000067683.84284.66. View

Van Heek N, Maitra A, Koopmann J, Fedarko N, Jain A, Rahman A . Gene expression profiling identifies markers of ampullary adenocarcinoma. Cancer Biol Ther. 2004; 3(7):651-6. DOI: 10.4161/cbt.3.7.919. View

Chang H, Kim S, Lee B, Hong E, Kim W . Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis. Pathol Int. 2004; 54(8):576-84. DOI: 10.1111/j.1440-1827.2004.01666.x. View

Hollingsworth M, Swanson B . Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2003; 4(1):45-60. DOI: 10.1038/nrc1251. View

Hinoda Y, Ikematsu Y, Horinochi M, Sato S, Yamamoto K, Nakano T . Increased expression of MUC1 in advanced pancreatic cancer. J Gastroenterol. 2004; 38(12):1162-6. DOI: 10.1007/s00535-003-1224-6. View

Capella C, Albarello L, Capelli P, Sessa F, Zamboni G . Carcinoma of the exocrine pancreas: the histology report. Dig Liver Dis. 2011; 43 Suppl 4:S282-92. DOI: 10.1016/S1590-8658(11)60584-7. View

Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H . Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater. Cancer. 1999; 86(4):596-607. View

Aloysius M, Zaitoun A, Awad S, Ilyas M, Rowlands B, Lobo D . Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. Br J Surg. 2010; 97(8):1269-78. DOI: 10.1002/bjs.7107. View

10.

Yuan Z, Wong S, Borrelli A, Chung M . Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007; 362(3):740-6. DOI: 10.1016/j.bbrc.2007.08.074. View

11.

Haddad L, Patzina R, Penteado S, Montagnini A, da Cunha J, Machado M . Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2010; 14(4):719-28. DOI: 10.1007/s11605-010-1156-4. View

12.

Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G . The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol. 2002; 26(4):466-71. DOI: 10.1097/00000478-200204000-00008. View

13.

Yu X, Rong W, Xu F, Xu G, Sun Y, Feng M . [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Ai Zheng. 2007; 26(11):1204-10. View

14.

Kalra A, Campbell R . Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. Br J Cancer. 2007; 97(7):910-8. PMC: 2360416. DOI: 10.1038/sj.bjc.6603972. View

15.

Westgaard A, Schjolberg A, Cvancarova M, Eide T, Clausen O, Gladhaug I . Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology. 2009; 54(3):337-47. PMC: 2680278. DOI: 10.1111/j.1365-2559.2009.03227.x. View

16.

Kawabata Y, Tanaka T, Nishisaka T, Inao T, Nishi T, Yano S . Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis. Diagn Pathol. 2010; 5:75. PMC: 3003636. DOI: 10.1186/1746-1596-5-75. View

17.

Gurbuz Y, Kloppel G . Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas. Virchows Arch. 2004; 444(6):536-41. DOI: 10.1007/s00428-004-1008-2. View

18.

Higashi M, Goto M, Saitou M, Shimizu T, Rousseau K, Batra S . Immunohistochemical study of mucin expression in periampullary adenomyoma. J Hepatobiliary Pancreat Sci. 2009; 17(3):275-83. DOI: 10.1007/s00534-009-0176-5. View

19.

Chu P, Schwarz R, Lau S, Yen Y, Weiss L . Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol. 2005; 29(3):359-67. DOI: 10.1097/01.pas.0000149708.12335.6a. View

20.

Sessa F, Furlan D, Zampatti C, Carnevali I, Franzi F, Capella C . Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch. 2007; 451(3):649-57. DOI: 10.1007/s00428-007-0444-1. View